Sandoz Group AG Stock
A loss of -2.780% shows a downward development for Sandoz Group AG.
Pros and Cons of Sandoz Group AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz confirms regulatory approval for new semaglutide treatment option in Brazil, paving way to expand patient access
Sandoz announces key leadership changes
Sandoz announces key leadership changes
Sandoz moves up Swiss equity rankings to join premier Swiss Market Index
Sandoz moves up Swiss equity rankings to join premier Swiss Market Index



